Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Ponte De Lima – page 5

312 clinical trials in Ponte De Lima, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Ponte De Lima at a glance
312
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

312 trials in Ponte De Lima

Open in trial search

Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-142
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Kura Oncology Inc.

A study testing the safety and effectiveness of BP1.

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:BP1.4979
  • Sponsor:Bioprojet Pharma

A study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:ALPHA-1-ANTITRYPSIN
  • Sponsor:Grifols Therapeutics LLC

A study comparing prasinezumab with placebo for people with early-stage Parkinson's disease

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Prasinezumab
  • Sponsor:F. Hoffmann-La Roche AG

A Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

A Study of Amivantamab and Lazertinib for Adults with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen Cilag International

A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ninerafaxstat trihydrochloride monohydrate
  • Sponsor:Imbria Pharmaceuticals Inc.

Osteoarthritis

Recruiting

A study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Montelukast
  • Sponsor:Farmalider S.A.

A Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Betovumeline
  • Sponsor:Maplight Therapeutics Inc.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Ponte De Lima

What the registry says about research in the country

01 Rheumatoid and Psoriatic Arthritis Studies

Innovative research focusing on rheumatoid arthritis and psoriatic arthritis treatments, evaluating new therapeutic approaches including zasocitinib and sonelokimab for patients who haven't received biological medicines.

  • Novel biologic therapies
  • Treatment comparisons
  • Disease activity reduction

Multiple trials are examining both established and experimental treatments for improved patient outcomes.

02 Autoimmune Conditions

Comprehensive studies targeting various autoimmune conditions, including Sjögren's Syndrome and Systemic Lupus Erythematosus, with a focus on evaluating new therapeutic options like dazodalibep and upadacitinib.

  • Systemic disease management
  • Long-term safety evaluation
  • Symptom control

Research aims to address both systemic manifestations and quality of life improvements.

03 Inflammatory Conditions

Studies investigating treatments for Crohn's Disease and Ulcerative Colitis, with particular attention to maintenance therapy and long-term disease management strategies.

  • Digestive system disorders
  • Extended treatment efficacy
  • Novel therapeutic approaches

Focus on developing sustainable treatment options for chronic inflammatory conditions.

04 Specialized Therapeutic Areas

Advanced research into conditions like Giant Cell Arteritis and Systemic Sclerosis, evaluating targeted treatments including secukinumab and HZN-825.

  • Rare disease interventions
  • Tissue-specific treatments
  • Progressive disease management

Emphasis on developing specialized treatments for complex medical conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.